Cell Culture Operator (Cell Banking) Part-time 60%
Novartis AG
Date de publication :
01 novembre 2024Taux d'activité :
60%- Lieu de travail :Basel (City)
#coveto_public h1{ font-weight: bold;}.custom-logo img { max-width: 300px; padding: 10px 0;}.custom-body{ max-width: 950px; margin: 0 auto;}.custom-paper { margin: 0 auto; background-color: #fff; border-radius: 10px; box-shadow: 0 0 10px rgba(0,0,0,0.3); padding: 20px; padding-top: 10px;}.custom-cta .ctabtnp,.custom-cta .ctabtnwa{ width: 100%; box-sizing: border-box;} For our client, an international trading company in the canton Zug, we are looking for:CFO (m/f/d) 80-100% (Canton Zug or Zurich) Responsibilities:Ensure accurate and compliant financial reporting according to Swiss accounting standards. Build and maintain strong relationships with financial institutions and auditors. Facilitate interactions with banks regarding credit lines, currency hedging, LC, and DC coordination. Represent the company's finance department to banks (including submitting payments and providing supporting documents) and other counterparties. Perform balance sheet closing, financial controlling, and prepare presentations for investors and banks. Manage cash flow planning and intra-group transactions. Maintain settings for accounting and other related software. Requirements:Professional experience in a similar role in commodity trading (MUST).Proficient in Swiss accounting practices and experienced in interacting with financial institutions and auditors. Experience in obtaining credit lines for commodity trade.Experience in Swiss banks (preferably).Hands-on execution skills.Fluency in German (native level) and English.C-permit or Swiss citizenship. If you can identify yourself with the requirements of this challenging position, we look forward to receiving your application (English CV and certificates/diplomas).For environmental and efficiency reasons, we would like to ask you to submit your application via our online application platform (click on "Apply") rather than by e-mail or by post
Contact
Novartis AG